Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Mitochondrial diseases stem from genetic mutations affecting oxidative phosphorylation.
• The mitochondrial proteome, including proteins in MitoCarta, has many uncharacterized proteins.
• Understanding these proteins is crucial for diagnosing and treating mitochondrial dysfunction.

Purpose of the Study:

• To review the applications of the CRISPR/Cas9 system in studying mitochondrial biology and diseases.
• To highlight how CRISPR/Cas9 facilitates the investigation of poorly characterized mitochondrial proteins.
• To explore the role of CRISPR/Cas9 in generating disease models and uncovering new mechanistic insights.

Main Methods:

• Utilizing CRISPR/Cas9 as a versatile and accurate genome editing tool.
• Employing gene editing to target specific genes involved in mitochondrial function.
• Leveraging CRISPR/Cas9 for generating cellular and animal models of mitochondrial diseases.
• Conducting large-scale genomic screenings to identify key pathways in mitochondrial health.

Main Results:

• CRISPR/Cas9 enables precise genetic manipulation for studying mitochondrial proteins.
• The system facilitates the creation of reliable disease models for research.
• Genomic screenings using CRISPR/Cas9 have revealed fundamental insights into mitochondrial processes.
• CRISPR/Cas9 aids in uncovering new pathomechanisms underlying mitochondrial disorders.

Conclusions:

• CRISPR/Cas9 is an indispensable tool for advancing research in mitochondrial biology and disease.
• Its applications are key to understanding the function of uncharacterized mitochondrial proteins.
• The technology offers significant potential for future discoveries in mitochondrial medicine.